Canada markets open in 1 hour 41 minutes

RVL Pharmaceuticals plc (O1P.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.00300.0000 (0.00%)
As of 08:31AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
36,919
49,721
17,501
27,762
240,031
Cost of Revenue
9,330
9,456
3,618
3,293
111,630
Gross Profit
27,589
40,265
13,883
24,469
128,401
Operating Expenses
Research Development
3,101
3,966
6,930
13,387
32,319
Selling General and Administrative
68,060
81,979
87,463
72,824
93,030
Total Operating Expenses
71,161
85,945
94,393
86,211
125,349
Operating Income or Loss
-43,572
-45,680
-80,510
-61,742
3,052
Interest Expense
11,375
3,110
4,018
4,095
18,211
Total Other Income/Expenses Net
-16,453
-5,779
1,994
-28,958
-282,863
Income Before Tax
-68,543
-51,712
-82,534
-94,795
-298,022
Income Tax Expense
-277
-20
315
-5,782
-27,121
Income from Continuing Operations
-68,266
-51,692
-82,849
-89,013
-270,901
Net Income
-68,266
-51,692
-64,920
-79,589
-270,901
Net Income available to common shareholders
-68,266
-51,692
-64,920
-79,589
-270,901
Basic EPS
-0.71
-0.58
-0.96
-1.31
-5.17
Diluted EPS
-0.71
-0.58
-0.96
-1.31
-5.17
Basic Average Shares
97,702
89,797
67,354
60,653
52,367
Diluted Average Shares
97,702
89,797
67,354
60,653
52,367